Airain Ltd’s Fortress Biotech FBIO Stock Holding History

Airain Ltd’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-782	Closed	-$23K	–	813
2014 Q1	$23K	Buy	+782	New	+$30.5K	﹤0.01%	682
2013 Q4	–	Sell	-840	Closed	-$88K	–	613
2013 Q3	$88K	Buy	+840	New	+$103K	0.02%	442

Other funds holding FBIO

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Airain Ltd's FBIO Position: Q2 2014 in Review

Airain Ltd sold out of Fortress Biotech (FBIO) in Q2 2014, closing a stake of 782 shares — an estimated $23K sold.

Airain Ltd first reported a position in FBIO in Q3 2013 and held it in 2 quarters. The position peaked at $88K in Q3 2013. 48 funds tracked by Wall St. Rank hold FBIO as of Q2 2014.

Airain Ltd reported no remaining Fortress Biotech position as of Q2 2014 after selling out during the quarter.
Airain Ltd sold 782 Fortress Biotech shares in Q2 2014, an estimated $23K.
Airain Ltd first reported a position in Fortress Biotech in Q3 2013 and held it in 2 quarters.
Airain Ltd's Fortress Biotech position peaked at $88K in Q3 2013.
48 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2014.

Based on Airain Ltd's 13F filing for Q2 2014, filed 5 Aug 2014.